Anthropic said to target mega-IPO before U.S. Thanksgiving


Anthropic had a net loss of almost US$42 billion in 2025, a roughly fivefold increase from about US$8.3 billion the year before, Bloomberg News reported in August. The company’s full-year revenue was roughly US$4.6 billion for 2025, up markedly from US$386 million in the year before, though its operating loss ballooned to more than US$8 billion, according to documents seen by Bloomberg News.



Source link

  • Related Posts

    Chelsea Toronto Unveils Renewed Brand Following $85 Transformation

    Chelsea Toronto is designed for people who want to experience the city in a way that fits their travel style. From corporate travellers to conference delegates, tour groups, families and…

    Continue reading
    Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs

    Based in East Brunswick, New Jersey, Cronus Pharma is a privately held veterinary generic pharmaceutical company dedicated to advancing animal health. With integrated research, development, manufacturing, and marketing, we deliver…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chelsea Toronto Unveils Renewed Brand Following $85 Transformation

    Happy Opt Out October! Let’s Find Real Alternatives to the Tech Giants

    Happy Opt Out October! Let’s Find Real Alternatives to the Tech Giants

    ICE sets limits on which officers can stop vehicles

    ICE sets limits on which officers can stop vehicles

    The $14 Billion Airport Being Built In The Middle Of Nowhere & Why Every Major Airline Wants In

    The $14 Billion Airport Being Built In The Middle Of Nowhere & Why Every Major Airline Wants In

    Parliamentary Secretary Mona Fortier to travel to Washington, D.C.

    Parliamentary Secretary Mona Fortier to travel to Washington, D.C.

    Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs